1. |
Raj SD, Shurafa M, Shah Z, Raj KM, Fishman MD, Dialani VM. Primary and secondary breast lymphoma: Clinical, pathologic, and multimodality imaging review. Radiographics 2019;39:610-25.
|
2. |
Thomas A, Link BK, Altekruse S, Romitti PA, Schroeder MC. Primary breast lymphoma in the United States: 1975-2013. J Natl Cancer Inst 2017;109 (6):djw294.
|
3. |
Zhang N, Cao C, Zhu Y, Liu P, Liu L, Lu K, et al. Primary breast lymphoma: A single center study. Oncol Lett 2017;13 (2):1014-8.
|
4. |
Picasso R, Tagliafico A, Calabrese M, Martinoli C, Pistoia F, Rossi A, et al. Primary and secondary breast lymphoma: Focus on epidemiology and imaging features. Pathol Oncol Res 2020;26:1483-8.
|
5. |
Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer 1972;29:1705-12.
|
6. |
Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ. Lymphomas involving the breast: A study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol 2008;32:1299-309.
|
7. |
Gualco G, Chioato L, Harrington WJ Jr., Weiss LM, Bacchi CE. Primary and secondary T-cell lymphomas of the breast: Clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol 2009;17:301-6.
|
8. |
Foo MY, Lee WP, Seah CM, Kam C, Tan SM. Primary breast lymphoma: A single-centre experience. Cancer Rep (Hoboken) 2019;2:e1140.
|
9. |
Wadhwa A, Senebouttarath K. Primary lymphoma of the breast: A case series. Radiol Case Rep 2018;13:815-21.
|
10. |
Montes-Mojarro IA, Steinhilber J, Bonzheim I, Quintanilla-Martinez L, Fend F. The pathological spectrum of systemic anaplastic large cell lymphoma (ALCL). Cancers (Basel) 2018;10:107.
|
11. |
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. 4 th ed. Lyon: International Agency for Research on Cancer (IARC); 2017.
|
12. |
Hapgood G, Savage KJ. The biology and management of systemic anaplastic large cell lymphoma. Blood 2015;126:17-25.
|
13. |
Quintanilla-Martinez L. The 2016 updated WHO classification of lymphoid neoplasias. Hematol Oncol 2017;35 Suppl 1:37-45.
|
14. |
Tsuyama N, Sakamoto K, Sakata S, Dobashi A, Takeuchi K. Anaplastic large cell lymphoma: Pathology, genetics, and clinical aspects. J Clin Exp Hematop 2017;57:120-42.
|
15. |
King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, et al. Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements. Am J Surg Pathol 2016;40:36-43.
|
16. |
Falini B. Anaplastic large cell lymphoma: Pathological, molecular and clinical features. Br J Haematol 2001;114:741-60.
|
17. |
Pereira EM, Maeda SA, Reis-Filho JS. Sarcomatoid variant of anaplastic large cell lymphoma mimicking a primary breast cancer: A challenging diagnosis. Arch Pathol Lab Med 2002;126:723-6.
|
18. |
Oishi N, Miranda RN, Feldman AL. Genetics of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 2019;39:S14-20.
|
19. |
Yu G, Gao Z, Huang X. ALK-positive anaplastic large cell lymphoma with an unusual alveolar growth pattern. Int J Clin Exp Pathol 2014;7:9086-9.
|
20. |
Xu J, Wei S. Breast implant-associated anaplastic large cell lymphoma: Review of a distinct clinicopathologic entity. Arch Pathol Lab Med 2014;138:842-6.
|